Process View
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the cell cycle regulator phosphoprotein p53, or an equivalent protein, in response to the detection of DNA damage, and ends when the execution phase of apoptosis is triggered.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "intrinsic apoptotic signaling pathway in response to dna damage by p53 class mediator"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 1.000 | ||
PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.986 | ||
NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.983 | ||
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.955 | ||
NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.903 | Human | |
REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.880 | ||
EP300 | E1A binding protein p300 | 0.750 | ||
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.664 | ||
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.626 | ||
NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.561 | Human | |
BRCA1 | breast cancer 1, early onset | 0.547 | ||
CREBBP | CREB binding protein | 0.465 | Human | |
BCL2 | B-cell CLL/lymphoma 2 | 0.432 | ||
CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.400 | ||
PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.364 | ||
NBN | nibrin | 0.362 | ||
TP53 | tumor protein p53 | 0.342 | ||
IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.289 | ||
ESR1 | estrogen receptor 1 | 0.284 | ||
BCL3 | B-cell CLL/lymphoma 3 | 0.281 | ||
DCAF7 | DDB1 and CUL4 associated factor 7 | 0.281 | ||
NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.263 | Human | |
IER3 | immediate early response 3 | 0.257 | ||
IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.241 | ||
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.219 | ||
HIPK2 | homeodomain interacting protein kinase 2 | 0.215 | Mouse | |
TNIP2 | TNFAIP3 interacting protein 2 | 0.201 | ||
PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.194 | ||
RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.181 | ||
PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.171 | Human | |
MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.159 | ||
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.142 | ||
RAD18 | RAD18 homolog (S. cerevisiae) | 0.139 | ||
RB1 | retinoblastoma 1 | 0.129 | ||
MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.108 | ||
RAD51 | RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) | 0.107 | Worm | |
ICAM1 | intercellular adhesion molecule 1 | 0.102 | ||
SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.098 | ||
PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.096 | ||
CHUK | conserved helix-loop-helix ubiquitous kinase | 0.094 | ||
FANCD2 | Fanconi anemia, complementation group D2 | 0.093 | ||
PML | promyelocytic leukemia | 0.093 | Mouse | |
LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.093 | Fly | |
UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.092 | ||
PARP1 | poly (ADP-ribose) polymerase 1 | 0.088 | ||
BTRC | beta-transducin repeat containing | 0.087 | ||
DAXX | death-domain associated protein | 0.085 | ||
BAX | BCL2-associated X protein | 0.084 | ||
NLRC4 | NLR family, CARD domain containing 4 | 0.082 | ||
PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha | 0.079 | ||
MSN | moesin | 0.079 | ||
BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.079 | ||
AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.077 | ||
KAT2B | K(lysine) acetyltransferase 2B | 0.077 | ||
SNIP1 | Smad nuclear interacting protein 1 | 0.077 | ||
LZTS2 | leucine zipper, putative tumor suppressor 2 | 0.076 | ||
HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.069 | ||
HDAC1 | histone deacetylase 1 | 0.061 | ||
PCNA | proliferating cell nuclear antigen | 0.059 | ||
KRT5 | keratin 5 | 0.056 | ||
SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.056 | ||
CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.055 | ||
TP53BP2 | tumor protein p53 binding protein, 2 | 0.055 | ||
PPFIA1 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | 0.054 | ||
BID | BH3 interacting domain death agonist | 0.054 | ||
BCL2L1 | BCL2-like 1 | 0.052 | ||
RPA1 | replication protein A1, 70kDa | 0.052 | ||
MOBKL1A | MOB1, Mps One Binder kinase activator-like 1A (yeast) | 0.046 | ||
IK | IK cytokine, down-regulator of HLA II | 0.044 | ||
SP100 | SP100 nuclear antigen | 0.044 | ||
NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.042 | ||
PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.040 | ||
HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.039 | ||
GSK3B | glycogen synthase kinase 3 beta | 0.039 | ||
UBR3 | ubiquitin protein ligase E3 component n-recognin 3 (putative) | 0.039 | ||
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.038 | ||
CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.038 | ||
FAS | Fas (TNF receptor superfamily, member 6) | 0.037 | ||
WWOX | WW domain containing oxidoreductase | 0.036 | ||
IL8 | interleukin 8 | 0.036 | ||
BRCA2 | breast cancer 2, early onset | 0.034 | Mouse | |
SNAI1 | snail homolog 1 (Drosophila) | 0.034 | ||
HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.031 | ||
YAP1 | Yes-associated protein 1 | 0.030 | ||
SMAD2 | SMAD family member 2 | 0.030 | ||
TNIP1 | TNFAIP3 interacting protein 1 | 0.030 | ||
BAK1 | BCL2-antagonist/killer 1 | 0.029 | ||
MSH3 | mutS homolog 3 (E. coli) | 0.028 | ||
IRF1 | interferon regulatory factor 1 | 0.028 | ||
AMOTL1 | angiomotin like 1 | 0.027 | ||
CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.027 | ||
MOBKL1B | MOB1, Mps One Binder kinase activator-like 1B (yeast) | 0.027 | ||
AR | androgen receptor | 0.027 | ||
DVL2 | dishevelled, dsh homolog 2 (Drosophila) | 0.027 | ||
STX5 | syntaxin 5 | 0.025 | ||
STK4 | serine/threonine kinase 4 | 0.025 | ||
UBE2D1 | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 0.024 | ||
PTK2 | PTK2 protein tyrosine kinase 2 | 0.023 | ||
POLH | polymerase (DNA directed), eta | 0.023 | ||
STK3 | serine/threonine kinase 3 | 0.023 | ||
RAD50 | RAD50 homolog (S. cerevisiae) | 0.023 | ||
SFN | stratifin | 0.023 | ||
WRN | Werner syndrome, RecQ helicase-like | 0.023 | ||
ANXA1 | annexin A1 | 0.022 | ||
PPP2R5D | protein phosphatase 2, regulatory subunit B', delta | 0.022 | Human | |
CAPG | capping protein (actin filament), gelsolin-like | 0.022 | ||
TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.022 | ||
JUB | jub, ajuba homolog (Xenopus laevis) | 0.022 | ||
RYBP | RING1 and YY1 binding protein | 0.021 | ||
ATM | ataxia telangiectasia mutated | 0.021 | ||
S100A4 | S100 calcium binding protein A4 | 0.020 | ||
UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 0.020 | ||
STRAP | serine/threonine kinase receptor associated protein | 0.020 | ||
ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.020 | ||
TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.019 | ||
SATB2 | SATB homeobox 2 | 0.019 | ||
RUNX1 | runt-related transcription factor 1 | 0.019 | ||
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.019 | Mouse | |
BCL2A1 | BCL2-related protein A1 | 0.019 | ||
ETF1 | eukaryotic translation termination factor 1 | 0.018 | ||
MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 0.018 | ||
SPRR2A | small proline-rich protein 2A | 0.018 | ||
TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.018 | ||
NOTCH1 | notch 1 | 0.018 | ||
DMC1 | DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast) | 0.018 | ||
BIRC3 | baculoviral IAP repeat containing 3 | 0.017 | ||
UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.017 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.017 | ||
LATS1 | LATS, large tumor suppressor, homolog 1 (Drosophila) | 0.017 | Fly | |
AMOTL2 | angiomotin like 2 | 0.017 | ||
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.017 | ||
STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.016 | ||
HUWE1 | HECT, UBA and WWE domain containing 1 | 0.016 | ||
STK38L | serine/threonine kinase 38 like | 0.016 | ||
VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.016 | ||
LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.016 | ||
MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.016 | ||
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.015 | ||
PPP2R5E | protein phosphatase 2, regulatory subunit B', epsilon isoform | 0.015 | Human | |
CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.015 | ||
CREB1 | cAMP responsive element binding protein 1 | 0.015 | ||
SIRT1 | sirtuin 1 | 0.014 | ||
RAD52 | RAD52 homolog (S. cerevisiae) | 0.014 | ||
SRGN | serglycin | 0.014 | ||
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.014 | ||
GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.014 | ||
PLK1 | polo-like kinase 1 | 0.014 | ||
INADL | InaD-like (Drosophila) | 0.014 | ||
PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 0.014 | ||
RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 | 0.014 | ||
XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.014 | ||
MAVS | mitochondrial antiviral signaling protein | 0.014 | ||
AHR | aryl hydrocarbon receptor | 0.013 | ||
OTUB1 | OTU domain, ubiquitin aldehyde binding 1 | 0.013 | ||
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.013 | ||
TDGF1 | teratocarcinoma-derived growth factor 1 | 0.013 | ||
RAD51C | RAD51 homolog C (S. cerevisiae) | 0.013 | ||
FOXO3 | forkhead box O3 | 0.013 | ||
RNF20 | ring finger protein 20 | 0.013 | ||
RPA2 | replication protein A2, 32kDa | 0.013 | ||
MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.012 | ||
CKAP5 | cytoskeleton associated protein 5 | 0.012 | ||
MFAP1 | microfibrillar-associated protein 1 | 0.012 | ||
MYST1 | MYST histone acetyltransferase 1 | 0.012 | ||
IRF2 | interferon regulatory factor 2 | 0.012 | ||
TP53BP1 | tumor protein p53 binding protein 1 | 0.012 | ||
NMI | N-myc (and STAT) interactor | 0.012 | ||
MAX | MYC associated factor X | 0.012 | ||
SAV1 | salvador homolog 1 (Drosophila) | 0.012 | ||
FAM117B | family with sequence similarity 117, member B | 0.012 | ||
SLC3A2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 | 0.012 | ||
AMOT | angiomotin | 0.012 | ||
MSH6 | mutS homolog 6 (E. coli) | 0.012 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.012 | ||
TOP1 | topoisomerase (DNA) I | 0.012 | ||
NCOA1 | nuclear receptor coactivator 1 | 0.011 | ||
PPM1D | protein phosphatase, Mg2+/Mn2+ dependent, 1D | 0.011 | ||
PALB2 | partner and localizer of BRCA2 | 0.011 | ||
WHSC1L1 | Wolf-Hirschhorn syndrome candidate 1-like 1 | 0.011 | ||
NCOA3 | nuclear receptor coactivator 3 | 0.011 | ||
FANCE | Fanconi anemia, complementation group E | 0.011 | ||
PPP6C | protein phosphatase 6, catalytic subunit | 0.011 | ||
FOXO1 | forkhead box O1 | 0.011 | ||
ABI2 | abl-interactor 2 | 0.011 | ||
XIAP | X-linked inhibitor of apoptosis | 0.011 | ||
NCOR1 | nuclear receptor corepressor 1 | 0.011 | ||
CFLAR | CASP8 and FADD-like apoptosis regulator | 0.011 | ||
BHLHE40 | basic helix-loop-helix family, member e40 | 0.011 | ||
MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.011 | ||
DZIP1 | DAZ interacting protein 1 | 0.011 | ||
RXRA | retinoid X receptor, alpha | 0.011 | ||
TMEM173 | transmembrane protein 173 | 0.011 | ||
VPRBP | Vpr (HIV-1) binding protein | 0.011 | ||
RAD54B | RAD54 homolog B (S. cerevisiae) | 0.011 | ||
SFPQ | splicing factor proline/glutamine-rich | 0.011 | ||
CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.011 | ||
ANXA5 | annexin A5 | 0.011 | ||
NINJ1 | ninjurin 1 | 0.011 | ||
GBP1 | guanylate binding protein 1, interferon-inducible | 0.010 | ||
PIAS3 | protein inhibitor of activated STAT, 3 | 0.010 | ||
PIM1 | pim-1 oncogene | 0.010 | ||
BCL10 | B-cell CLL/lymphoma 10 | 0.010 | ||
MAPK8 | mitogen-activated protein kinase 8 | 0.010 | ||
PPP1R3F | protein phosphatase 1, regulatory (inhibitor) subunit 3F | 0.010 | ||
CARD11 | caspase recruitment domain family, member 11 | 0.010 | ||
S100A2 | S100 calcium binding protein A2 | 0.010 | ||
RNF38 | ring finger protein 38 | 0.010 |